Oncosec Medical Incorporated — Department of Health and Human Services SBIR Phase I: DESCRIPTION (provided by applicant): Here we seek to develop a more effective and targeted
Oncosec Medical Incorporated — SBIR Phase I award from Department of Health and Human Services.
- Amount
- $162,701
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR · Phase I
- Solicitation
- PA13-234
- NAICS
- —
- Place of performance
- CA
- Period
- —
Description
DESCRIPTION (provided by applicant): Here we seek to develop a more effective and targeted electroporation device for the clinical treatment of cancerous solid tumors. The application of using electroporation to transfect therapeutic agents into a tumor cells in the clinician setting is an exciting approach to a targeted treatment of cancer. The challenge for this work is to further develop a clinical electroporation device that will use the phenomenon of wave interference to produce a targeted electroporation waveform to increase the effectiveness of transfection. PUBLIC HEALTH RELEVANCE PUBLIC HEALTH RELEVANCE: OncoSec Medical Incorporated is a small biopharmaceutical company developing its advanced-stage OMS ElectroOncology therapies to treatlocal solid tumor cancers and metastatic disease. OMS ElectroOncology therapies address an unmet medical need and represent a potential solution, for less invasive and less expensive therapies that are able to minimize the detrimental effects resultin